These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 30397278)

  • 1. Developmental influence of unconjugated hyperbilirubinemia and neurobehavioral disorders.
    Amin SB; Smith T; Timler G
    Pediatr Res; 2019 Jan; 85(2):191-197. PubMed ID: 30397278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of bilirubin neurotoxicity by the Abcb1 transporter in the Ugt1-/- lethal mouse model of neonatal hyperbilirubinemia.
    Bockor L; Bortolussi G; Vodret S; Iaconcig A; Jašprová J; Zelenka J; Vitek L; Tiribelli C; Muro AF
    Hum Mol Genet; 2017 Jan; 26(1):145-157. PubMed ID: 28025333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Movement disorders due to bilirubin toxicity.
    Rose J; Vassar R
    Semin Fetal Neonatal Med; 2015 Feb; 20(1):20-25. PubMed ID: 25524299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Neurological Sequelae of Neonatal Hyperbilirubinemia: Definitions, Diagnosis and Treatment of the Kernicterus Spectrum Disorders (KSDs).
    Le Pichon JB; Riordan SM; Watchko J; Shapiro SM
    Curr Pediatr Rev; 2017; 13(3):199-209. PubMed ID: 28814249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of neuro-inflammation improves survival and neurodegeneration in a mouse model of severe neonatal hyperbilirubinemia.
    Vodret S; Bortolussi G; Iaconcig A; Martinelli E; Tiribelli C; Muro AF
    Brain Behav Immun; 2018 May; 70():166-178. PubMed ID: 29458193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kernicterus on the Spectrum.
    Kasirer Y; Kaplan M; Hammerman C
    Neoreviews; 2023 Jun; 24(6):e329-e342. PubMed ID: 37258501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns.
    Watchko JF
    Neuromolecular Med; 2006; 8(4):513-29. PubMed ID: 17028373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metalloporphyrins for treatment of unconjugated hyperbilirubinemia in neonates.
    Suresh GK; Martin CL; Soll RF
    Cochrane Database Syst Rev; 2003; (2):CD004207. PubMed ID: 12804504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtle bilirubin-induced neurodevelopmental dysfunction (BIND) in the term and late preterm infant: does it exist?
    Lunsing RJ
    Semin Perinatol; 2014 Nov; 38(7):465-71. PubMed ID: 25281356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extreme neonatal hyperbilirubinemia, acute bilirubin encephalopathy, and kernicterus spectrum disorder in children with galactosemia.
    Bech LF; Donneborg ML; Lund AM; Ebbesen F
    Pediatr Res; 2018 Aug; 84(2):228-232. PubMed ID: 29892033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An update on unconjugated neonatal hyperbilirubinaemia in Denmark].
    Donneborg ML; Hansen BM; Petersen JP; Vandborg PK; Ebbesen F
    Ugeskr Laeger; 2020 Mar; 182(14A):. PubMed ID: 32285792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jaundice and kernicterus in the moderately preterm infant.
    Wallenstein MB; Bhutani VK
    Clin Perinatol; 2013 Dec; 40(4):679-88. PubMed ID: 24182955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperbilirubinemia, hemolysis, and increased bilirubin neurotoxicity.
    Kaplan M; Bromiker R; Hammerman C
    Semin Perinatol; 2014 Nov; 38(7):429-37. PubMed ID: 25284470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of bilirubin-induced neurologic dysfunction on neurodevelopmental outcomes.
    Wusthoff CJ; Loe IM
    Semin Fetal Neonatal Med; 2015 Feb; 20(1):52-57. PubMed ID: 25585889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental onset of bilirubin-induced neurotoxicity involves Toll-like receptor 2-dependent signaling in humanized UDP-glucuronosyltransferase1 mice.
    Yueh MF; Chen S; Nguyen N; Tukey RH
    J Biol Chem; 2014 Feb; 289(8):4699-709. PubMed ID: 24403077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of bilirubin neurotoxicity II: preventing and treating acute bilirubin encephalopathy and kernicterus spectrum disorders.
    Shapiro SM; Riordan SM
    Pediatr Res; 2020 Jan; 87(2):332-337. PubMed ID: 31581172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of inflammatory processes to nerve cell toxicity by bilirubin and efficacy of potential therapeutic agents.
    Fernandes A; Brites D
    Curr Pharm Des; 2009; 15(25):2915-26. PubMed ID: 19754368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns.
    Wennberg RP; Ahlfors CE; Bhutani VK; Johnson LH; Shapiro SM
    Pediatrics; 2006 Feb; 117(2):474-85. PubMed ID: 16452368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-6-Phosphate Dehydrogenase Deficiency and the Need for a Novel Treatment to Prevent Kernicterus.
    Cunningham AD; Hwang S; Mochly-Rosen D
    Clin Perinatol; 2016 Jun; 43(2):341-54. PubMed ID: 27235212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroinflammation and ER-stress are key mechanisms of acute bilirubin toxicity and hearing loss in a mouse model.
    Schiavon E; Smalley JL; Newton S; Greig NH; Forsythe ID
    PLoS One; 2018; 13(8):e0201022. PubMed ID: 30106954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.